Literature DB >> 30441076

In vitro Measurement of Release Kinetics of Temperature Sensitive Liposomes with a Fluorescence Imaging System.

Davud Asemani, Anjan Motamarry, Dieter Haemmerich.   

Abstract

Temperature sensitive liposomes (TSL) are a promising type of nanoparticles for localized drug delivery. TSL typically release the contained drug at mild hyperthermic temperatures (40-42 °C). Combined with localized hyperthermia, this allows for local drug delivery. In vitro characterization of TSL involves measurements of drug release at varying temperatures, but current methods are inadequate due to low temporal resolution of ~8 - 10 seconds. We present a novel method for measuring the drug release with sub-second temporal resolution. In the proposed system, the TSL entrapping the fluorescent drug (Doxorubicin) are pumped through a capillary tube. The tube is rapidly heated to a desired temperature via Peltier element. Since fluorescence increases as drug is released from TSL, drug release kinetics can be measured via fluorescent imaging. By fitting exponential models, we calculated the time constants of drug release at temperatures of 39.5, 40.5 and 41.5.C were about 6.09, 2.06 and 1.03 seconds, respectively. Our initial tests show that the developed system can measure TSL release at subsecond resolution, and thus allow adequate in vitro evaluation of TSL formulations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30441076      PMCID: PMC6521836          DOI: 10.1109/EMBC.2018.8512942

Source DB:  PubMed          Journal:  Annu Int Conf IEEE Eng Med Biol Soc        ISSN: 2375-7477


  11 in total

1.  Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ari Partanen; Pavel S Yarmolenko; David Woods; Bradford J Wood; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

2.  Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound.

Authors:  Ayele H Negussie; Pavel S Yarmolenko; Ari Partanen; Ashish Ranjan; Genevieve Jacobs; David Woods; Henry Bryant; David Thomasson; Mark W Dewhirst; Bradford J Wood; Matthew R Dreher
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

3.  Design of liposomes for enhanced local release of drugs by hyperthermia.

Authors:  M B Yatvin; J N Weinstein; W H Dennis; R Blumenthal
Journal:  Science       Date:  1978-12-22       Impact factor: 47.728

4.  Drug release kinetics of temperature sensitive liposomes measured at high-temporal resolution with a millifluidic device.

Authors:  Caitlin Burke; Matthew R Dreher; Ayele H Negussie; Andrew S Mikhail; Pavel Yarmolenko; Aakash Patel; Brenden Skilskyj; Bradford J Wood; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2017-12-28       Impact factor: 3.914

5.  A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.

Authors:  D Needham; G Anyarambhatla; G Kong; M W Dewhirst
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

Review 6.  Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer.

Authors:  Ronnie T P Poon; Nicholas Borys
Journal:  Expert Opin Pharmacother       Date:  2009-02       Impact factor: 3.889

7.  Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.

Authors:  Li Li; Timo L M ten Hagen; Martin Hossann; Regine Süss; Gerard C van Rhoon; Alexander M M Eggermont; Dieter Haemmerich; Gerben A Koning
Journal:  J Control Release       Date:  2013-03-21       Impact factor: 9.776

8.  A novel method for mapping the heterogeneity in blood supply to normal and malignant tissues in the mouse dorsal window chamber.

Authors:  Kathrine S Øye; Geeta Gulati; Bjørn A Graff; Jon-Vidar Gaustad; Kjetil G Brurberg; Einar K Rofstad
Journal:  Microvasc Res       Date:  2007-08-06       Impact factor: 3.514

9.  Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.

Authors:  Ashley A Manzoor; Lars H Lindner; Chelsea D Landon; Ji-Young Park; Andrew J Simnick; Matthew R Dreher; Shiva Das; Gabi Hanna; Won Park; Ashutosh Chilkoti; Gerben A Koning; Timo L M ten Hagen; David Needham; Mark W Dewhirst
Journal:  Cancer Res       Date:  2012-09-04       Impact factor: 12.701

10.  Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Frank Rattay; Bradford J Wood; Dieter Haemmerich
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more
  3 in total

1.  Real-time fluorescence imaging for visualization and drug uptake prediction during drug delivery by thermosensitive liposomes.

Authors:  Anjan Motamarry; Ayele H Negussie; Christian Rossmann; James Small; A Marissa Wolfe; Bradford J Wood; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2019       Impact factor: 3.914

2.  Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities.

Authors:  Anjan Motamarry; A Marissa Wolfe; Krishna K Ramajayam; Sanket Pattanaik; Thomas Benton; Yuri Peterson; Pegah Faridi; Punit Prakash; Katherine Twombley; Dieter Haemmerich
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

3.  Closed-loop trans-skull ultrasound hyperthermia leads to improved drug delivery from thermosensitive drugs and promotes changes in vascular transport dynamics in brain tumors.

Authors:  Chulyong Kim; Yutong Guo; Anastasia Velalopoulou; Johannes Leisen; Anjan Motamarry; Krishna Ramajayam; Muna Aryal; Dieter Haemmerich; Costas D Arvanitis
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.